Enhanced Self-Emulsifying Cannabidiol Formulations with Improved Bioavailability and Stability

The present inventive concept relates to novel self-emulsifying cannabidiol compositions exhibiting improved bioavailability and stability, addressing the limitations of existing formulations. The inventive concept introduces a novel emulsifier derived from coconut oil and a pH-adjusting agent, enabling a rapid onset of action and a prolonged duration of therapeutic effect.

The original patent disclosed self-emulsifying cannabidiol compositions with limitations in terms of bioavailability and stability. The present inventive concept addresses these limitations by introducing novel components and adaptations that enhance the composition's performance, providing a more effective and reliable treatment option for diseases and withdrawal symptoms.

The inventive concept comprises self-emulsifying cannabidiol compositions containing from about 1% to about 40% w/w cannabidiol and from about 40% to about 99% w/w of one or more surfactants, including a novel emulsifier derived from coconut oil. The composition may further include a pH-adjusting agent, ensuring a stable pH over a range of temperatures. The inventive concept also encompasses methods for treating anxiety disorders and enhancing the solubility of cannabidiol, as well as a system for preparing the self-emulsifying composition with a consistent average globule size of less than 200 nanometers.

The inventive concept's novelty lies in the introduction of the novel emulsifier derived from coconut oil and the pH-adjusting agent, which provide improved bioavailability and stability. The inventive step resides in the combination of these components with the existing surfactants, resulting in a composition that exhibits a rapid onset of action and a prolonged duration of therapeutic effect.

Alternative embodiments of the inventive concept may include varying the ratio of cannabidiol to surfactants, using different types of emulsifiers, or incorporating additional components to enhance the composition's performance. Variations may also include adapting the composition for specific disease indications or developing different formulations for different routes of administration.

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the treatment of anxiety disorders and other diseases. The improved bioavailability and stability of the self-emulsifying cannabidiol compositions make them an attractive option for patients and healthcare providers, offering a more effective and reliable treatment option.